Company: JUNS
Filing Date: 2025-11-06
Form Type: DEF 14A
Source: 0001493152-25-020988
Chunk: 57

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-06
Form: DEF 14A
Chunk 57
---
POSAL NO. 2:

INCREASE IN AUTHORIZED SHARES OF COMMON STOCK</div>

The Board recommends that the stockholders adopt an amendment to the certificate of incorporation to increase the number of authorized shares (the “ Authorized Shares Increase”) of Common Stock by 375,000,000, from 125,000,000 to 500,000,000 (representing an increase of 300%), so that the total number of authorized shares of the Company’s Common Stock and Preferred Stock will be increased from 130,000,000 to 505,000,000. Pursuant to the Company’s certificate of incorporation, the Company currently has 5,000,000 shares of its Preferred Stock and 125,000,000 shares of Common Stock authorized. As of October 24, 2025, there were 34,426,355 shares of Common Stock issued and outstanding.

The Board believes it is desirable for the Company to have a sufficient number of shares of Common Stock available for the satisfaction of its existing obligations to issue shares of Common Stock and possible future financings or acquisition transactions, stock dividends or splits, stock issuances pursuant to employee benefit plans and other proper corporate purposes. It is possible that some of these additional shares could be used for various other purposes without further stockholder approval, except as such approval may be required in particular cases by the Company’s certificate of incorporation, applicable law or the rules of any stock exchange or other quotation system on which the Company’s securities may then be listed. The Board believes that approval of the Share Authorization Proposal is crucial predominantly to ensure that the Company has sufficient authorized shares to meet its existing obligations to issue shares of Common Stock as and if they become due, and to secure needed financing without incurring the delay and expense of holding additional stockholders’ meetings.

If the Share Authorization Proposal is approved, up to an additional 375,000,000 shares of Common Stock, would be issued and outstanding or available for future issuance. The additional shares of Common Stock will have the same rights as the presently authorized shares of Common Stock, including the right to cast one vote per share of Common Stock. Although the authorization of additional shares will not, in itself, have any effect on the rights of any holder of our Common Stock, the future issuance of additional shares of Common Stock (other than by way of a stock split or dividend) would have the effect of diluting the voting rights and could have the effect of diluting earnings per share and book value per share of existing stockholders.

The